Want to see HUM full AI Analyst Report?
HUM Stock Chart & Stats
$205.14
$0.14(0.05%)
At close: 4:00 PM EST
$205.14
$0.14(0.05%)
Day’s Range― - ―
52-Week Range$163.11 - $428.88
Previous CloseN/A
Volume197.44K
Average Volume (3M)1.38M
Market Cap
$48.02B
Enterprise Value$34.98K
Total Cash (Recent Filing)$21.96B
Total Debt (Recent Filing)$13.99B
Price to Earnings (P/E)42.6
Beta0.81
Next Earnings
Jul 29, 2026EPS Estimate
7.25Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)9.38
Shares Outstanding120,061,500
10 Day Avg. Volume1,146,202
30 Day Avg. Volume1,379,451
Financial Highlights & Ratios
PEG Ratio-18.55
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$334.63Price Target Upside63.12% Upside
Rating ConsensusHold
Number of Analyst Covering20
EPS Forecast (FY)8.95
Revenue Forecast (FY)$162.16B
Bulls Say, Bears Say
Bulls Say
Membership & Revenue GrowthSustained membership gains—Medicaid adds and on‑track Medicare Advantage growth—drive recurring premium flows and scale. Over months this increases negotiating leverage with providers, spreads fixed admin costs across more lives, and stabilizes top-line predictability for capitated revenue.
CenterWell Clinical Expansion & M&AExpanding CenterWell primary care and targeted M&A increases vertical integration, boosting Humana’s ability to manage total cost of care long term. Owning care access points supports value‑based contracting, improves care coordination, and creates durable margin upside if utilization and outcomes are managed.
Improved Liquidity & Contingent CapitalEstablishing pre‑capitalized trusts and issuing subordinated notes enhances committed funding capacity and liquidity optionality. This structural financing reduces refinancing risk, supports regulatory capital flexibility, and preserves runway for 2027 obligations and strategic investments.
Bears Say
Sharply Compressed MarginsNet margin compression to ~0.9% materially reduces the cushion against adverse medical trends and raises earnings cyclicality. With lower margins, Humana has less ability to absorb utilization shocks, increasing sensitivity of ROE and the difficulty of meeting multi‑year margin recovery targets.
Weak And Volatile Cash ConversionSignificantly lower free cash flow conversion versus prior years constrains internal funding for buybacks, M&A, and capital needs. Persistent volatility in operating cash makes long‑term capital allocation harder and raises refinancing or external funding reliance during stress.
Contingent Funding Risk From Put ExposureA possible $1.0–$1.5B cash obligation from counterparty put options is a structural liquidity tail risk. Even if planned for, exercise would force near‑term capital redeployment, complicate reserve funding and limit optionality for strategic investments or shareholder returns.
HUM FAQ
What was Humana’s price range in the past 12 months?
Humana lowest stock price was $163.11 and its highest was $428.88 in the past 12 months.
What is Humana’s market cap?
Humana’s market cap is $48.02B.
When is Humana’s upcoming earnings report date?
Humana’s upcoming earnings report date is Jul 29, 2026 which is in 10 days.
How were Humana’s earnings last quarter?
Humana released its earnings results on Apr 29, 2026. The company reported $10.31 earnings per share for the quarter, beating the consensus estimate of $10.245 by $0.065.
Is Humana overvalued?
According to Wall Street analysts Humana’s price is currently Undervalued.
Does Humana pay dividends?
Humana pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 1.38%. See more information on Humana dividends here
What is Humana’s EPS estimate?
Humana’s EPS estimate is 7.25.
How many shares outstanding does Humana have?
Humana has 120,061,500 shares outstanding.
What happened to Humana’s price movement after its last earnings report?
Humana reported an EPS of $10.31 in its last earnings report, beating expectations of $10.245. Following the earnings report the stock price went up 5.833%.
Which hedge fund is a major shareholder of Humana?
Currently, no hedge funds are holding shares in HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$334.63 (63.12% Upside)
$334.63 (63.12% Upside)
Blogger Sentiment
Bullish
HUM Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 2.2%
Last 30 Days ▲ 2.2%
News Sentiment
Very Bullish
Bullish news 90%
Bearish news 10%
Bearish news 10%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.51%
12-Months-Change
Fundamentals
Return on Equity
6.19%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
Humana
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
HUM Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income

HUM Stock 12 Month Forecast
Average Price Target
$334.63
▲(63.12% Upside)
Technical Analysis
Ownership Overview
0.26% Insiders
36.00% Mutual Funds
0.09% Other Institutional Investors
37.01% Public Companies and
Individual Investors












